Avantor (AVTR) to Release Earnings on Wednesday

Avantor (NYSE:AVTRGet Free Report) will be announcing its earnings results before the market opens on Wednesday, February 14th. Analysts expect the company to announce earnings of $0.22 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Avantor Price Performance

Shares of NYSE AVTR opened at $23.65 on Wednesday. The stock has a market capitalization of $16.00 billion, a P/E ratio of 43.80, a P/E/G ratio of 1.41 and a beta of 1.36. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.60 and a quick ratio of 1.03. Avantor has a 1 year low of $16.63 and a 1 year high of $25.25. The company’s 50-day moving average is $22.24 and its 200 day moving average is $21.17.

Hedge Funds Weigh In On Avantor

Several institutional investors have recently bought and sold shares of the stock. Creative Planning grew its stake in Avantor by 28.9% during the third quarter. Creative Planning now owns 16,486 shares of the company’s stock valued at $348,000 after acquiring an additional 3,699 shares in the last quarter. Royal Bank of Canada increased its holdings in shares of Avantor by 50.1% in the 3rd quarter. Royal Bank of Canada now owns 306,126 shares of the company’s stock worth $6,454,000 after buying an additional 102,170 shares during the last quarter. Schroder Investment Management Group increased its holdings in shares of Avantor by 29.2% in the 3rd quarter. Schroder Investment Management Group now owns 36,984 shares of the company’s stock worth $780,000 after buying an additional 8,364 shares during the last quarter. Stifel Financial Corp increased its holdings in shares of Avantor by 16.6% in the 3rd quarter. Stifel Financial Corp now owns 41,941 shares of the company’s stock worth $884,000 after buying an additional 5,981 shares during the last quarter. Finally, Osaic Holdings Inc. increased its holdings in shares of Avantor by 8.5% in the 2nd quarter. Osaic Holdings Inc. now owns 135,243 shares of the company’s stock worth $2,777,000 after buying an additional 10,574 shares during the last quarter. 89.04% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of recent analyst reports. Morgan Stanley cut their price target on shares of Avantor from $24.00 to $22.00 and set an “overweight” rating on the stock in a report on Monday, October 30th. The Goldman Sachs Group increased their price objective on shares of Avantor from $23.00 to $26.00 and gave the company a “buy” rating in a research report on Thursday, December 7th. TD Cowen upgraded shares of Avantor from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $21.00 to $28.00 in a research report on Monday, December 11th. Barclays increased their price target on shares of Avantor from $21.00 to $24.00 and gave the stock an “overweight” rating in a research report on Monday, December 11th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $28.00 price target on shares of Avantor in a research report on Tuesday, January 9th. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Avantor presently has a consensus rating of “Moderate Buy” and an average target price of $24.83.

Check Out Our Latest Stock Report on Avantor

About Avantor

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Stories

Earnings History for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.